|
Volumn 10, Issue 11, 2002, Pages
|
Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CONJUGATED ESTROGEN;
CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE;
ESTRADIOL;
ESTROGEN;
ISOFLAVONE DERIVATIVE;
MEDROXYPROGESTERONE ACETATE;
PHYTOESTROGEN;
PLANT MEDICINAL PRODUCT;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
CHEMISTRY;
CLIMACTERIUM;
DRUG COMBINATION;
DRUG EFFECT;
DRUG FORMULATION;
DRUG MONITORING;
ESTROGEN THERAPY;
FEMALE;
HUMAN;
MENOPAUSE;
METHODOLOGY;
PATIENT CARE PLANNING;
PHYSIOLOGY;
POSTMENOPAUSE OSTEOPOROSIS;
REVIEW;
RISK FACTOR;
CHEMISTRY, PHARMACEUTICAL;
CLIMACTERIC;
DRUG COMBINATIONS;
DRUG COMPOUNDING;
DRUG MONITORING;
ESTRADIOL;
ESTROGEN REPLACEMENT THERAPY;
ESTROGENS, CONJUGATED (USP);
ESTROGENS, NON-STEROIDAL;
FEMALE;
HUMANS;
ISOFLAVONES;
MEDROXYPROGESTERONE 17-ACETATE;
MENOPAUSE;
OSTEOPOROSIS, POSTMENOPAUSAL;
PATIENT CARE PLANNING;
PHYTOESTROGENS;
PLANT PREPARATIONS;
RALOXIFENE;
RISK FACTORS;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
|
EID: 18744419935
PISSN: 10966293
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (4)
|
References (27)
|